Abstract:This review was undertaken to ascertain the clinical benefit of topical antibiotics in the treatment of acne vulgaris by pooling data from different studies. Specifically, we wished to determine whether topical antibiotics could be ranked in order of therapeutic efficacy and to determine the relative efficacy of topical antibiotics compared with oral tetracycline and topical benzoyl peroxide. Of 135 studies published between January 1966 and April 1989, identified using Medline, 62 reported the results of clinical trials of one or more topical antibiotics. Nine additional articles were identified by hand searching through bibliographies of articles already found, and by contacting the manufacturers of topical antibiotics in the UK. A questionnaire was sent to 50 clinical investigators in order to estimate any possible publication bias resulting from contradictory findings of unpublished studies. Study quality was assessed using four primary and five secondary criteria including overall trial design, clinical technique and methods of data analysis. Because of major deficiencies in study methods, 33 trials were excluded from the final data analysis. Disappointingly, almost all of the remaining trials contained defects either of overall trial design or of reporting. In addition, the considerable variations in a number of parameters meant that few meaningful comparisons could be carried out. The results of 15 double-blind, placebo-controlled trials showed that topical erythromycin was effective against inflamed lesions in concentrations ranging from 1% to 4% with or without the addition of zinc. The effectiveness of topical clindamycin, but not topical tetracycline, against inflamed lesions has also been adequately demonstrated. However, none of the topical antibiotics has been shown to be more effective than benzoyl peroxide. The relative efficacy of topical antibiotics and oral tetracycline has not been reliably established. Replies to the questionnaire identified 17 unpublished trials. In only one instance was it clear that non-publication was due to negative results. Whilst this overview has shown that some topical antibiotic preparations are of clinical benefit, further well-designed studies are needed to identify the range of acne severity which responds to such therapy and to determine the relative efficacy of topical antibiotics and oral tetracycline. In future, efforts should be made to standardize as many features of trial design as possible and to ensure that full details of all aspects of the trials are adequately reported. Journals should be more rigorous in their refereeing of dermatological trials.

VACCINE THERAPY AND OTHER TREATMENT IN ACNE VULGARIS AND FURUNCULOSIS

Treatment Opportunities and Technological Progress Prospective for Acne Vulgaris

Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes

Vaccinating against Acne: Benefits and Potential Pitfalls

Immunotherapy for Acne Vulgaris: Current Status and Future Directions

INDIVIDUAL ARTCLE: Pathophysiologic Targets of Acne Treatment

Medicinal Plants and their Constituents in the Treatment of Acne vulgaris

A Practice Approach to Acne Fulminans in Adolescents

Propionibacterium acnes in the Pathogenesis and Immunotherapy of Acne Vulgaris

COMPREHENSIVE MANAGEMENT OF ACNE VULGARIS: AN UPDATE ON THERAPEUTIC APPROACHES

TRADITIONAL AND ALTERNATIVE METHODS OF ACNE TREATMENT

Topical Treatment and Aesthetic Procedures in Management of Acne Vulgaris

Decoding Acne Vulgaris: Insights into Pathogenesis, Treatment Modalities, Diagnosis and Recent Advancements

Acne vulgaris: new evidence in pathogenesis and future modalities of treatment

The Essential Role of Herbal-based Therapies in Combatting Acne Vulgaris

Evaluation of serum levels of interleukins 1‐beta, 10 and 12 in patients with acne vulgaris

Serum Uric Acid and Folic Acid Levels in Acne Vulgaris Patients

Targeting Inflammation in Acne: Current Treatments and Future Prospects

Topical antibiotics for the treatment of acne vulgaris: A critical evaluation of the literature on their clinical benefit and comparative efficacy

Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability

Penatalaksanaan Acne Vulgaris